Neostigmine
- Product NDC
- 43598-528
- 11-digit product format
- 435980528
- Labeler code
- 43598
- Product ID
- 43598-528_649d8760-81df-13da-6556-14a0fdbc8b02
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Neostigmine
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Dr.Reddy's Laboratories Inc
- Application
- ANDA209135
- Marketing category
- ANDA
- Marketing start
- 2018-09-04
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 98IMH7M386 | NEOSTIGMINE METHYLSULFATE | 51-60-5 | NEOSTIGMINE METHYLSULFATE |
| 3982TWQ96G | NEOSTIGMINE | 59-99-4 | Neostigmine |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 43598-528-11 | 43598052811 | 1 VIAL, MULTI-DOSE in 1 CARTON (43598-528-11) / 10 mL in 1 VIAL, MULTI-DOSE | 2018-09-04 | No | No | Historical |
| 43598-528-36 | 43598052836 | 10 VIAL, MULTI-DOSE in 1 CARTON (43598-528-36) / 10 mL in 1 VIAL, MULTI-DOSE | 2018-09-04 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Neostigmine | Dr.Reddy's Laboratories Inc | Gland Pharma Ltd | 2021-02-02 | HUMAN PRESCRIPTION DRUG LABEL | 4 |